Innovation and the pharmaceutical industry : critical reflections on the virtues of profit
Author(s)
Bibliographic Information
Innovation and the pharmaceutical industry : critical reflections on the virtues of profit
（Conflicts and trends : studies in values and policies / senior editor H. Tristram Engelhardt, Jr.）
M & M Scrivener Press, c2008
- : hbk.
Available at / 1 libraries
-
No Libraries matched.
- Remove all filters.
Note
Includes bibliographical references and index
Contents of Works
- Pharmaceutical innovation and the market : the pursuit of profit and the amelioration of the human condition / H. Tristram Engelhardt Jr. & Jeremy R. Garrett
- The unavoidable goodness of profit : the cunning of reason and the realization of human well-being / H. Tristram Engelhardt Jr
- Corporate social responsibility and business ethics in the pharmaceutical industry / Nicholas Capaldi
- Pharmaceutical companies and their obligations to developing countries : psychopaths or scapegoats? / Pepe Lee Chang
- Autonomy, constraining options, and pharmaceutical costs / James Stacy Taylor
- Pharmaceutical advertising and patient autonomy / Andrew I. Cohen
- Why America does not have a second drug problem / Richard A. Epstein
- Global drug innovation in a world of financial finitude : retailing virtue to promote capital formation and profit / Michael A. Rie
- Time, money, and the market for drugs / John C. Goodman
- Perils of parallel trade : reimporting prescription drugs from Canada to the U.S / John R. Graham
- Risk, responsibility, and litigation / Sandra H. Johnson & Ana Smith Iltis
Description and Table of Contents
Description
Innovation and the Pharmaceutical Industry: Critical Reflections on the Virtues of Profit examines the central role of profit in the development of pharmaceuticals, medical devices, and health care generally. Recent efforts to understand this role have often underestimated and even dismissed its importance, arguing for its replacement by other means and mechanisms. However, as the essays in this volume attest, it would be impossible to account adequately for the range of pharmaceuticals and medical devices that have become part of everyday medicine without recognizing that the depth and scope of innovations are tied not simply to altruism, a concern for the common good, or the pursuit of knowledge for its own sake, but crucially to the pursuit of private good and of individual profit. Balancing a concern for theory and practice, the analyses and evaluations provided in these essays touch directly on many of the most heated and important debates in pharmaceutical ethics, such as profit margins, corporate social responsibility, drug advertising, litigation, patents, and parallel trade. Reflecting critically on the problems and prospects of medical innovation, they invite a rethinking of the foundations of the bioethics and business ethics of the pharmaceutical and medical device industries by focusing on the long-term impact of policy decisions for human health and well-being.
by "Nielsen BookData"
